Publication | Open Access
Comparison of the immunogenicity of <scp>BNT162b2</scp> and <scp>CoronaVac COVID</scp> ‐19 vaccines in Hong Kong
174
Citations
32
References
2021
Year
Vaccination with BNT162b2 induces stronger humoral responses than CoronaVac. CoronaVac induces higher CD4<sup>+</sup> and CD8<sup>+</sup> T-cell responses to the structural protein than BNT162b2.
| Year | Citations | |
|---|---|---|
Page 1
Page 1